 BEVERLY, Mass., Nov. 18, 2020 GLOBE NEWSWIRE -- LexaGene Holdings, Inc., TSX-V: LXG; OTCQB: LXXGF the Company, a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce that it has placed a MiQLabTM system into the clinical microbiology laboratory at the University of Pennsylvanias School of Veterinary Medicine Penn Vet as part of its Early Access Program. Penn Vet provides testing for animal patients at both the Ryan Veterinary Hospital and patients of practices across the US, processing thousands of samples each year. 